Regardless of the partner (7q32.3, other or unknown), tested PTCL cases with monoallelic 6p25.3 alterations exhibited DUSP22 down-regulation [12], making it a candidate tumor-suppressor at this locus. This evidence concerns the gene DUSP22 and neoplasm.